Morning Briefing
Summaries of health policy coverage from major news organizations
Perspectives: Pharmacy Benefit Managers Need Regulation; Should Kids Be Using GLP-1s For Weight Loss?
Read recent commentaries about pharmaceutical issues.
The ongoing legal dispute involving Johnson & Johnson has again thrust the topic of pharmacy benefit managers (PBMs) into the spotlight. Ann Lewandowski, a J&J employee, sued the company for overpaying for its employees’ prescription drugs through its PBM, Express Scripts, claiming that these overpayments resulted in higher health insurance premiums and out-of-pocket drug costs for employees. (Jake Frenz, 6/12)
In the face of a growing childhood obesity epidemic, some parents and clinicians are turning to new tools such as GLP-1 receptor agonists. (6/5)
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
